申请人:SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
公开号:US10174011B2
公开(公告)日:2019-01-08
The present invention provides a heterocyclic compound represented by the formula (I), its stereoisomers, or a pharmaceutically acceptable salt thereof, pharmaceutical compositions thereof, and their use in preparing a medicament for the prevention and/or treatment of central nervous system disease.
本发明提供了一种由式(I)代表的杂环化合物、其立体异构体或其药学上可接受的盐、其药物组合物,以及它们在制备预防和/或治疗中枢神经系统疾病的药物中的用途。